Collegium Medicum w Bydgoszczy

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Use of Flozins (Empagliflozin/Dapagliflozin) for Prevention of AKI	Arterial Occlusive Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, acute kidney injury, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, kidney disorder, kidney failure, myocardial ischemia, urinary system disorder, vascular disorder	Recruiting	Not stated	2025-11-17		NCT07231939

Clinical trials